RS51131B - Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama - Google Patents
Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijamaInfo
- Publication number
- RS51131B RS51131B RSP-2009/0347A RSP20090347A RS51131B RS 51131 B RS51131 B RS 51131B RS P20090347 A RSP20090347 A RS P20090347A RS 51131 B RS51131 B RS 51131B
- Authority
- RS
- Serbia
- Prior art keywords
- beta
- unsaturated ketones
- reducing alpha
- opioid compositions
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Postupak za smanjenje količine α, β-nezasićenih ketona u opioidnojanalgetičkoj kompoziciji koji se sastoji od hidrogenizacije polazne opioidne analgetičke kompozicija koja ima nečistoće α, β -nezasićenih ketona sa diimidom, 10 jedinjenjem koje daje diimid ili njihovom kombinacijom u pogodnom rastvaraču, da bi se dobila rezultujuća opioidna analgetička kompozicija koja ima nivo α, β -nezasićenih ketona manji od polazne kompozicije, a gde je opioidni analgetik jedinjenje formule (I):gdeR je izabran iz grupe koju čine vodonik; C1-8 alkil; C3-6cikloalkil; (C3-6)cikloalkil(C1-3)alkil; fenil(C1-3)alkil; i fenil(C1-3)alkil supstituisan sa 1-3 člana grupe koju čine C1-8 alkil, trifiuorometil, nitro, dialkilamino i cijano;R1 je izabran iz grupe koju čine vodonik; C1-8alkil; C3-6cikloalkil;C1-8alkoksi; C3-6cikloalkoksi; 2-(4-morfolinil)etil; benziloksikarbonil; (R8)3C(O)-; fenil(C1-3)alkil; i fenil(C1-3)alkil supstituisan sa 1-3 člana grupe koju čine C1-8 alkil, trifluorometil, nitro, dialkilamino i cijano;R2 je izabran iz grupe koju čine vodonik; okso; hidroksil; C1-8 alkil; C1-8alkoksi; C3-6cikloalkil; i C3-6.cikloalkoksi; iR3 je vodonik; hidroksil; ili alkoksi;R8 je nezavisno vodonik, C1-4 alkil, C3-6cikloalkil, fenil ili benzil gde je R2 okso kada je veza u položaju 7-8 zasićena; ili njegova farmaceutski prihvatljiva so.Prijava sadrži još 18 zavisnih patentnih zahteva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65879105P | 2005-03-04 | 2005-03-04 | |
| PCT/EP2006/001798 WO2006094672A1 (en) | 2005-03-04 | 2006-02-27 | Method of reducing alpha, beta unsaturated ketones in opioid compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51131B true RS51131B (sr) | 2010-10-31 |
Family
ID=36301669
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20110031A RS51568B (sr) | 2005-03-04 | 2006-02-27 | Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama |
| RSP-2009/0347A RS51131B (sr) | 2005-03-04 | 2006-02-27 | Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20110031A RS51568B (sr) | 2005-03-04 | 2006-02-27 | Postupak smanjenja alfa, beta nezasićenih ketona u opioidnim kompozicijama |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7939543B2 (sr) |
| EP (2) | EP1861405B1 (sr) |
| JP (1) | JP5314894B2 (sr) |
| KR (1) | KR100941761B1 (sr) |
| CN (1) | CN101133062B (sr) |
| AT (2) | ATE487722T1 (sr) |
| CA (1) | CA2598774C (sr) |
| CY (2) | CY1109262T1 (sr) |
| DE (2) | DE602006018208D1 (sr) |
| DK (2) | DK2112153T3 (sr) |
| ES (2) | ES2326491T3 (sr) |
| HK (2) | HK1111695A1 (sr) |
| HR (2) | HRP20090387T1 (sr) |
| ME (2) | ME01594B (sr) |
| PL (2) | PL1861405T3 (sr) |
| PT (2) | PT2112153E (sr) |
| RS (2) | RS51568B (sr) |
| SI (2) | SI2112153T1 (sr) |
| WO (1) | WO2006094672A1 (sr) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE10361596A1 (de) * | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| PT1842533E (pt) * | 2003-08-06 | 2013-05-17 | Gruenenthal Gmbh | Forma de dosagem protegida contra abuso |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| TWI483944B (zh) | 2004-03-30 | 2015-05-11 | Euro Celtique Sa | 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| CN101395159A (zh) | 2006-03-02 | 2009-03-25 | 马林克罗特公司 | 制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法 |
| US7906647B2 (en) | 2006-12-04 | 2011-03-15 | Noramco, Inc. | Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone |
| AU2007329451B2 (en) * | 2006-12-04 | 2012-08-30 | Noramco, Llc | Process for reducing impurities in oxycodone base |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| CA2684458A1 (en) * | 2007-04-16 | 2008-10-30 | Mallinckrodt Inc. | Novel opiate reduction utilizing catalytic hydrogen transfer reaction |
| FR2923484B1 (fr) * | 2007-11-09 | 2012-11-09 | Sanofi Aventis | Procede de preparation de composes morphiniques |
| TWI454288B (zh) | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | 藥物劑型 |
| US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| MX2010009990A (es) * | 2008-03-11 | 2010-12-15 | Depomed Inc | Formas de dosificación gástricas retentivas de liberación prolongada que comprenden combinaciones de un analgésico no opioide y un analgésico opioide. |
| PT2273983T (pt) | 2008-05-09 | 2016-10-28 | Gruenenthal Gmbh | Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização |
| ES2560210T3 (es) * | 2009-07-22 | 2016-02-17 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación |
| CN102573805A (zh) * | 2009-07-22 | 2012-07-11 | 格吕伦塔尔有限公司 | 热熔挤出的控制释放剂型 |
| RU2012112552A (ru) * | 2009-08-31 | 2013-10-10 | Дипомед, Инк. | Удерживаемые в желудке фармацевтические композиции для немедленного и продленного высвобождения ацетаминофена |
| US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| EP2377866B1 (en) | 2010-03-23 | 2014-02-26 | Siegfried AG | Preparation of low impurity opiates in a continuous flow reactor |
| ES2645725T3 (es) | 2010-06-11 | 2017-12-07 | Rhodes Technologies | Procesos catalizados por metales de transición para la preparación de compuestos de N-alilo y uso de los mismos |
| EP2580218B1 (en) | 2010-06-11 | 2015-02-25 | Rhodes Technologies | Process for n-dealkylation of tertiary amines |
| RU2604676C2 (ru) | 2010-09-02 | 2016-12-10 | Грюненталь Гмбх | Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль |
| TWI516286B (zh) | 2010-09-02 | 2016-01-11 | 歌林達股份有限公司 | 含陰離子聚合物之抗破碎劑型 |
| US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
| US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
| US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
| CN103857386A (zh) | 2011-07-29 | 2014-06-11 | 格吕伦塔尔有限公司 | 提供药物立即释放的抗破碎片剂 |
| LT2736495T (lt) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu |
| JP6117249B2 (ja) | 2012-02-28 | 2017-04-19 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形 |
| CA2868142A1 (en) | 2012-04-18 | 2013-10-24 | Grunenthal Gmbh | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| EP2970320B1 (en) * | 2013-03-15 | 2020-10-28 | Johnson Matthey Public Limited Company | Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain |
| US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
| CN105682643B (zh) | 2013-07-12 | 2019-12-13 | 格吕伦塔尔有限公司 | 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型 |
| AU2014356581C1 (en) | 2013-11-26 | 2020-05-28 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
| US9062062B1 (en) | 2013-12-18 | 2015-06-23 | Cody Laboratories, Inc. | Synthesis of oxycodone hydrochloride |
| US8846923B1 (en) | 2013-12-18 | 2014-09-30 | Cody Laboratories, Inc. | Preparation of 14-hydroxycodeinone sulfate |
| US10227354B2 (en) | 2013-12-18 | 2019-03-12 | Cody Laboratories, Inc. | Conversion of oxycodone base to oxycodone hydrochloride |
| EP3142646A1 (en) | 2014-05-12 | 2017-03-22 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| US9872835B2 (en) | 2014-05-26 | 2018-01-23 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
| CA2954600A1 (en) | 2014-07-09 | 2016-01-14 | Rhodes Technologies | Reduction of alpha, beta-unsaturated ketone levels in morphinan derivative compositions |
| CN107889459A (zh) | 2015-04-24 | 2018-04-06 | 格吕伦塔尔有限公司 | 具有立即释放和对溶剂萃取的抗性的抗篡改剂型 |
| EP3346991A1 (en) | 2015-09-10 | 2018-07-18 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3812312A (en) | 1971-11-15 | 1974-05-21 | Chrysler Corp | Impact velocity sensor switch with linearly movable controller |
| US5869669A (en) | 1996-07-26 | 1999-02-09 | Penick Corporation | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
| GB9713703D0 (en) | 1997-06-30 | 1997-09-03 | Johnson Matthey Plc | Preparation of opiates |
| US6177567B1 (en) * | 1999-10-15 | 2001-01-23 | Boehringer Ingelheim Chemicals, Inc. | Method for preparing oxycodone |
| TWI483944B (zh) * | 2004-03-30 | 2015-05-11 | Euro Celtique Sa | 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
-
2006
- 2006-02-27 ME MEP-2011-17A patent/ME01594B/me unknown
- 2006-02-27 CA CA2598774A patent/CA2598774C/en active Active
- 2006-02-27 SI SI200630885T patent/SI2112153T1/sl unknown
- 2006-02-27 PT PT09158939T patent/PT2112153E/pt unknown
- 2006-02-27 JP JP2007557403A patent/JP5314894B2/ja active Active
- 2006-02-27 DE DE602006018208T patent/DE602006018208D1/de active Active
- 2006-02-27 AT AT09158939T patent/ATE487722T1/de active
- 2006-02-27 ES ES06707309T patent/ES2326491T3/es active Active
- 2006-02-27 EP EP06707309A patent/EP1861405B1/en active Active
- 2006-02-27 US US11/885,402 patent/US7939543B2/en active Active
- 2006-02-27 WO PCT/EP2006/001798 patent/WO2006094672A1/en active Application Filing
- 2006-02-27 KR KR1020077022566A patent/KR100941761B1/ko active IP Right Grant
- 2006-02-27 CN CN200680006690.5A patent/CN101133062B/zh active Active
- 2006-02-27 SI SI200630344T patent/SI1861405T1/sl unknown
- 2006-02-27 RS RS20110031A patent/RS51568B/sr unknown
- 2006-02-27 RS RSP-2009/0347A patent/RS51131B/sr unknown
- 2006-02-27 ME MEP-2009-248A patent/ME01184B/me unknown
- 2006-02-27 DE DE602006006558T patent/DE602006006558D1/de active Active
- 2006-02-27 ES ES09158939T patent/ES2355870T3/es active Active
- 2006-02-27 DK DK09158939.0T patent/DK2112153T3/da active
- 2006-02-27 AT AT06707309T patent/ATE430153T1/de active
- 2006-02-27 PL PL06707309T patent/PL1861405T3/pl unknown
- 2006-02-27 EP EP09158939A patent/EP2112153B1/en active Active
- 2006-02-27 PL PL09158939T patent/PL2112153T3/pl unknown
- 2006-02-27 PT PT06707309T patent/PT1861405E/pt unknown
- 2006-02-27 DK DK06707309T patent/DK1861405T3/da active
-
2008
- 2008-03-06 HK HK08102671.4A patent/HK1111695A1/xx unknown
-
2009
- 2009-07-07 HR HR20090387T patent/HRP20090387T1/xx unknown
- 2009-07-23 CY CY20091100790T patent/CY1109262T1/el unknown
-
2010
- 2010-04-13 HK HK10103566.6A patent/HK1135107A1/xx unknown
-
2011
- 2011-02-01 HR HR20110078T patent/HRP20110078T1/hr unknown
- 2011-02-03 CY CY20111100129T patent/CY1111241T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1135107A1 (en) | Method of reducing alpha, beta- unsaturated ketones in opioid compositions | |
| MX2008010921A (es) | Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados. | |
| MA32301B1 (fr) | 1-aryl-3-amino-alcoxypyrazoles comme ligands de sigma augmentant l'effet analgesique d'opioides et attenuant la dependance a ceux-ci | |
| EA201100748A1 (ru) | Пиразиновые соединения в качестве ингибиторов фосфодиэстеразы 10 | |
| NZ602862A (en) | Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | |
| EP1783166A4 (en) | RESIN COMPOSITION AND PROCESS FOR PRODUCING LAMINATE USING THE SAME | |
| WO2011060304A3 (en) | Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions | |
| WO2009117676A3 (en) | Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase | |
| MY155478A (en) | Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
| MY150082A (en) | Trans-clomiphene for metabolic syndrome | |
| MX2011008885A (es) | Composiciones, sintesis y metodos para usar derivados de arilpiperazina. | |
| WO2011060297A3 (en) | Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions | |
| DK2044067T3 (da) | Fremgangsmåde til fremstilling af 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octanbromid | |
| UA96994C2 (ru) | Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии | |
| EP1942170A4 (en) | ACCELERATORS FOR OZONE OXIDATION, OZONE OXIDIZING COMPOUND COMPOSITION, AND OZONE PROCESSING | |
| MX2007010400A (es) | Nuevas sales de derivados de hexahidrofenantridina sustituida con 6-heterociclilo. | |
| WO2009154993A8 (en) | Compositions, synthesis, and methods of using piperazine based antipsychotic agents | |
| MX2009011858A (es) | Composiciones de (-)-e-10-oh-nt y metodos para su sintesis y uso. | |
| MX2011006845A (es) | Inhibidores de glyt1 biciclicos 3.1.0 y metodos para elaboracion y utilizacion de los mismos. | |
| ATE531755T1 (de) | Zusammensetzung mit einem polymer und einem oxidationskatalysator | |
| ATE511760T1 (de) | Nuss-stückchen enthaltendes kaugummi | |
| EP2305803A4 (en) | THERMOSTABLE 1,5-ANHYDROGLUCITOL DEHYDROGENASE AND METHOD OF MEASURING 1,5-ANHYDROGLUCITOL USING THE SAME | |
| WO2009112709A3 (fr) | Nouveau procede pour la preparation d'extraits de ginkgo biloba | |
| WO2008011161A3 (en) | Dermal anesthetic compounds | |
| MX2009003200A (es) | Procedimiento para la preparacion de pradofloxacino. |